Vadodara, India, July 8, 2024 – Sudeep
Pharma Private Limited's promoters have completed the
acquisition of shares from their joint venture partners - JRS PHARMA, regaining
100% ownership of the company. This strategic move represents a significant
step in Sudeep Pharma’s ongoing growth and development, enabling the company to
pursue its vision.
Promoters of Sudeep Pharma, Mr. Sujit Bhayani & Family,
entered into a joint venture in 2015 with JRS Pharma. Combining JRS Pharma’s
expertise in excipients with Sudeep Pharma's technological advancements and
robust manufacturing capabilities resulted in significant growth and valuable
cooperation over the past nine years.
Sudeep Pharma remains dedicated to delivering cutting-edge
pharmaceutical solutions, maintaining the highest standards of quality, and
ensuring continued customer satisfaction. The company is poised to accelerate
its research and development initiatives, expand its product portfolio, and
pursue new opportunities for global market leadership.
Both Sudeep Pharma and JRS Pharma assure all stakeholders that
this transaction will have no impact on current operations or product
availability. Customers can expect to receive the same exceptional levels of
service and product quality that both companies have consistently provided.
About Sudeep Pharma Private Limited:
Established in 1989, Sudeep Pharma Group is a leading
manufacturer of specialty ingredients for the pharmaceutical, nutraceutical,
and food industries. Starting with one excipient manufacturing facility, the
group has expanded significantly, now operating six manufacturing facilities
globally. Sudeep Pharma offers a comprehensive product
portfolio that includes pharmaceutical excipients, mineral
actives, and specialty ingredients tailored for the nutraceutical and food
industries. The company prioritizes leveraging its technological expertise to
innovate solutions for sustained growth.
Committed to setting new benchmarks in the healthcare industry,
Sudeep Pharma aims to continue expanding its business both organically and
inorganically. The company is actively enhancing its presence in India, the
USA, and Europe through its subsidiaries, maintaining a strong focus on
quality, integrity, and customer satisfaction.